Imaging Surveillance and Risk-Based Management of Known Genetic Mutations in Breast Cancer: A Radiologist’s Guide
Journal of Breast Imaging · 2025
DOI: 10.1093/jbi/wbaf054 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Breast Imaging, 2025. Verfasst von Motaz Daraghma und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Missouri-Kansas City, Kansas City, MO, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Magnetic Resonance Imaging. Die Arbeit nennt 98 Literaturangaben.
Abstract (Originalsprache)
As genetic testing expands, radiologists increasingly care for carriers of pathogenic variants associated with inherited breast cancer. Across the literature and current guidelines, 3 themes emerge. First, gene-specific screening is essential. High-penetrance variants (BRCA1/2, TP53, PALB2, PTEN) warrant intensified surveillance, with annual MRI as the cornerstone and mammography tailored by gene and age. For moderate-penetrance variants (eg, ATM, CHEK2), risk-adapted strategies are recommended, with MRI considered when lifetime risk is ≥20% or when additional risk factors are present. Second, MRI provides the greatest incremental cancer detection in patients who are high risk; contrast-enhanced mammography and US may be reasonable alternatives when MRI is unavailable or contraindicated. Third, mutation-associated cancers show patterns that can reduce missed and interval cancers when radiologists stay alert to gene-specific presentations and background parenchymal enhancement on MRI. Radiologists play a central role in longitudinal surveillance and in counseling about risk-reducing options in coordination with genetics and surgery. These points translate the evidence into practical, gene-informed imaging care for patients with inherited breast cancer risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Missouri-Kansas City, Kansas City, MO, USA.
- University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
ORCID-Profile: Motaz Daraghma
Zitieren
APA
Daraghma, M., Alatoum, A., Thompson Jacinto, B. M., Kestelman, F. P., Fahed, R. I., Policeni, F. C., & Kim Hsieh, S. J. (2025). Imaging Surveillance and Risk-Based Management of Known Genetic Mutations in Breast Cancer: A Radiologist’s Guide. Journal of Breast Imaging. https://doi.org/10.1093/jbi/wbaf054
Vancouver
Daraghma M, Alatoum A, Thompson Jacinto BM, Kestelman FP, Fahed RI, Policeni FC, et al. Imaging Surveillance and Risk-Based Management of Known Genetic Mutations in Breast Cancer: A Radiologist’s Guide. Journal of Breast Imaging. 2025. doi:10.1093/jbi/wbaf054
BibTeX
@article{Daraghma2025,
author = {Daraghma, Motaz and Alatoum, Aiah and Thompson Jacinto, Bruna M and Kestelman, Fabiola P and Fahed, Reine I and Policeni, Fabiana C and Kim Hsieh, Su J},
title = {Imaging Surveillance and Risk-Based Management of Known Genetic Mutations in Breast Cancer: A Radiologist’s Guide},
journal = {Journal of Breast Imaging},
year = {2025},
doi = {10.1093/jbi/wbaf054}
}
EUVIMED